Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
The American Journal of Cardiology|December 8, 2009
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathyElena Biagini, Paolo Spirito, Guido Rocchi, et al.
Pharmaceutics|May 28, 2022
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected PairMichele Schlich, Luca Casula, Aurora Musa, et al.
International Journal of Molecular Sciences|January 28, 2026
Whole-Exome Sequencing Identifies Novel Genetic Variants Associated with Unexplained Neurodevelopmental Disorders in ChildrenGiancarlo Mancuso, Laura Serventi, Chiara Cocco, et al.
International Journal of Pharmaceutics|August 6, 2022
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodentMaria Cristina Cardia, Maria Francesca Palmas, Luca Casula, et al.
International Journal of Nanomedicine|November 27, 2025
Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson's Disease Targeting α-SynucleinLuca Casula, Maria Francesca Palmas, Maria Cristina Cardia, et al.
The American Journal of Cardiology|March 18, 2014
Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factorsPaolo Spirito, Camillo Autore, Francesco Formisano, et al.
BMJ Open Respiratory Research|July 30, 2026
Telomere dysfunction and mucociliary impairment drive idiopathic pulmonary fibrosis susceptibility: insights from a Sardinian whole-exome studyStefano Mocci, Roberto Littera, Silvia Deidda, et al.
Scientific Reports|November 26, 2024
Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysisElisa Gelli, Claudia Martinuzzi, Debora Soncini, et al.
The American Journal of Cardiology|June 13, 2016
Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic CardiomyopathyElena Biagini, Chiara Pazzi, Iacopo Olivotto, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-MonothiopomalidomideMaria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola, et al.
Pageof 10